Qube Research & Technologies LTD Procept Bio Robotics Corp Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 232,994 shares of PRCT stock, worth $8.95 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
232,994
Previous 159,705
45.89%
Holding current value
$8.95 Million
Previous $12.9 Million
5.56%
% of portfolio
0.02%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding PRCT
# of Institutions
303Shares Held
43.5MCall Options Held
286KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$197 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$134 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$82.3 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$54.4 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$49.9 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.71B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...